Last updated 2026-09-15
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
$5.2M
total disclosed, rounds participated
Stages
—
About
Prof. Michel Revel is an Israeli virologist and biotechnologist, best known for his work on interferon and the cloning of human interferon beta (IFN-β) genes, which led to the development of a drug for multiple sclerosis. He is also a co-founder and Chief Scientist of the Israeli biotechnology company Kadimastem. Claire Revel is an advocate for women in STEM, business, and leadership, and an avid philanthropist. She is also involved in running two tech companies.
Portfolio · 1
Q&A
- Who are Prof. Michel and Claire Revel?
- Prof. Michel Revel is an Israeli virologist and biotechnologist, co-founder and Chief Scientist of Kadimastem. Claire Revel is an advocate for women in STEM and business, and a philanthropist involved in running two tech companies.
- What is Prof. Michel Revel known for in his scientific career?
- Prof. Michel Revel is best known for his work on interferon and the cloning of human interferon beta (IFN-β) genes, which led to the development of a drug for multiple sclerosis.
- What is the primary sector focus for Prof. Michel and Claire Revel's investment activities?
- Prof. Michel and Claire Revel primarily focus on the Health Tech & Life Sciences sector.
- In which geographical region do Prof. Michel and Claire Revel prefer to invest?
- Prof. Michel and Claire Revel prefer to invest in Israel.
- What is the role of Prof. Michel Revel at Kadimastem?
- Prof. Michel Revel is a co-founder and the Chief Scientist of the Israeli biotechnology company Kadimastem.
- What is Claire Revel's involvement in the tech industry?
- Claire Revel is involved in running two tech companies, in addition to her advocacy and philanthropic work.